
Japan Tissue Engineering Co., Ltd.
President & CEO
As we begin a new chapter, I, Kazuto Yamada, have had the honor and privilege to be appointed President of Japan Tissue Engineering Co., Ltd.
I joined the company as a new graduate in June 2000, one year after its establishment. At that time, the term "regenerative medicine," which refers to treatments using cells, did not yet exist, and it was called "tissue engineering." After joining, I was assigned to the research and development department, where I was involved in joint research with academic professors and the development of autologous cultured epidermis "JACE" and autologous cultured cartilage "JACC." Later, I was transferred to the quality control department, where I was responsible for the shipment inspection of the first autologous cultured epidermis "JACE."
Since 2013, as the head of quality assurance, I have been deeply involved in ensuring the quality, efficacy, and safety of all five products, including autologous cultured epidermis "JACE," autologous cultured cartilage "JACC," and autologous cultured corneal epithelium "NEPIC," as well as in the regenerative medicine contract business and research and development support business.
The deep knowledge of quality assurance that I have accumulated over the years will be utilized in all aspects of management going forward. Additionally, my experience of closely collaborating with members from various departments from the perspective of quality assurance is an invaluable asset.
With many of the founding members retiring, we are transitioning to a new executive team. I will promote a "team-based management" approach that maximizes the strengths of each department, moving away from the previous "charismatic management" style. By fostering a culture where each employee thinks and proposes ideas proactively and by further strengthening interdepartmental collaboration, we will prioritize providing value to all stakeholders, including patients, and contribute to business growth and enhancement of corporate value.
We kindly ask for your continued support and guidance.